{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:33:14Z","timestamp":1764783194610},"reference-count":20,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2010,5,24]],"date-time":"2010-05-24T00:00:00Z","timestamp":1274659200000},"content-version":"vor","delay-in-days":3583,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Obstet and Gynaecol"],"published-print":{"date-parts":[[2000,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Objective:<\/jats:bold> Our purpose was to evaluate the efficacy and safety of ambroxol for the prenatal prophylaxis of infant respiratory distress syndrome (IRDS).<\/jats:p><jats:p><jats:bold>Study Design:<\/jats:bold> This was a prospective study with 2 groups of pregnant patients with premature labor or with premature rupture of membranes at an estimated gestation between 27 to 34 completed weeks. Ambroxol treatment group consisted of 39 subjects in whom 1,000 mg of ambroxol diluted in 500 m<jats:italic>l<\/jats:italic> of 5% glucose solution was given intravenously for 4 hours once a day for 3 days, while the control group consisted of 41 subjects in whom ambroxol was not administered. Main measures included Apgar scores, clinical signs of one or more of the following: respiratory rate of &gt; 60\/min, intercostal retraction, alar flaring, expiratory grunting, cyanosis on room air and radiological evidence of IRDS. Chi\u2010square test was used to determine the statistical significance of the results.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Tolerable maternal side effects were noted. Profile of newborns delivered were similar in both groups. Incidence of IRDS was significantly less in the treatment group (p &lt; 0.01).<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> Antenatal administration of ambroxol resulted in a significant decrease in the incidence of IRDS as well as perinatal morbidity and mortality. Due to the efficacy and safety of this drug, it might be useful for the prevention of IRDS.<\/jats:p>","DOI":"10.1111\/j.1447-0756.2000.tb01327.x","type":"journal-article","created":{"date-parts":[[2010,5,26]],"date-time":"2010-05-26T20:51:46Z","timestamp":1274907106000},"page":"307-312","source":"Crossref","is-referenced-by-count":20,"title":["Antenatal Use of Ambroxol for the Prevention of Infant Respiratory Distress Syndrome"],"prefix":"10.1111","volume":"26","author":[{"given":"Jovelle B.","family":"Laoag\u2010Fernandez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex M.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Maruo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,5,24]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"S57","article-title":"Ambroxol for prevention and treatment of hyaline membrane disease","volume":"3","author":"Wauer RR","year":"1989","journal-title":"Eur Respir J (suppl)"},{"key":"e_1_2_1_3_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0028-2243(89)90115-9","article-title":"Lung surfactant enhancement in utero","volume":"32","author":"Renzo GC","year":"1989","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"e_1_2_1_4_2","first-page":"204","article-title":"Antenatal ambroxol usage in the prevention of respiratory distress syndrome: Beneficial and adverse effects","volume":"22","author":"Kimya K.","year":"1995","journal-title":"Clin Exp Obstet Gynecol"},{"key":"e_1_2_1_5_2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJM198609253151308","article-title":"Surfactant replacement","volume":"315","author":"Avery ME","year":"1986","journal-title":"N Engl J Med"},{"key":"e_1_2_1_6_2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1542\/peds.50.4.515","article-title":"A controlled trial of antepartum glucocorticoid treatment for prevention of respiratory distress syndrome in premature infants","volume":"50","author":"Liggins GC","year":"1972","journal-title":"Pediatrics"},{"key":"e_1_2_1_7_2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/21548331.1980.11946657","article-title":"Glucocroticoids in the prevention of repiratory distress syndrome","volume":"15","author":"Ballard PL","year":"1980","journal-title":"Hosp Pract"},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0022-3476(75)80839-0","article-title":"Glucocorticoid prophylaxis for respiratory distress syndrome, a review of potential toxicity","volume":"87","author":"Tauesch HW.","year":"1975","journal-title":"J Pediatr"},{"key":"e_1_2_1_9_2","first-page":"99","article-title":"Glucocorticoids and the respiratory distress syndrome","volume":"13","author":"Johnson JW","year":"1984","journal-title":"Obstet Gynecol Annual"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1515\/jpme.1987.15.3.227"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.0450515"},{"key":"e_1_2_1_12_2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1542\/peds.63.1.64","article-title":"Risk of respiratory distress syndrome after prenatal dexamethasone treatment","volume":"63","author":"Tauesch HW","year":"1979","journal-title":"Pediatrics"},{"key":"e_1_2_1_13_2","first-page":"113","article-title":"Prenatal prophylaxis of hyaline membrane disease with prednisolone: Advantages and disadvantages","volume":"4","author":"Wauer RR","year":"1983","journal-title":"Biol Res Pregnancy Perinatol"},{"key":"e_1_2_1_14_2","first-page":"S255","article-title":"The pharmacology of ambroxol\u2010review and new results","volume":"153","author":"Disse BG.","year":"1987","journal-title":"Eur Respir Dis (Suppl)"},{"key":"e_1_2_1_15_2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000195315","article-title":"Ambroxol increases the choline but not fatty acid incorporation into lung phospholipids in experimental lung disorders","volume":"52","author":"Wilke A.","year":"1987","journal-title":"Respiration"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)82056-6"},{"key":"e_1_2_1_17_2","first-page":"662","article-title":"Prevention of hyaline membrane disease","volume":"134","author":"Gerger A.","year":"1986","journal-title":"Monatsschr Kinderhelikd"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1515\/jpme.1987.15.5.453"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02113258"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-0496(199902)27:2<104::AID-PPUL6>3.0.CO;2-T"},{"key":"e_1_2_1_21_2","first-page":"443","article-title":"Ambroxol versus betamethasone for the promotion of lung maturity in pathologic pregnancies","volume":"102","author":"Heytmanek G.","year":"1990","journal-title":"Wien Klin Wochenschr"}],"container-title":["Journal of Obstetrics and Gynaecology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1447-0756.2000.tb01327.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1447-0756.2000.tb01327.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T11:57:45Z","timestamp":1698580665000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1447-0756.2000.tb01327.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,8]]}},"alternative-id":["10.1111\/j.1447-0756.2000.tb01327.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1447-0756.2000.tb01327.x","archive":["Portico"],"relation":{},"ISSN":["1341-8076","1447-0756"],"issn-type":[{"value":"1341-8076","type":"print"},{"value":"1447-0756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,8]]}}}